Get started
Award

Pid2020-117116rb-i00

Funded outputs count: 12
Funder award ID: PID2020-117116RB-I00
OpenAlex ID: G6586213331
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism
2026 · Pietro Guerra, Gianmarco Villano, et al. · British Journal of Cancer · 1
Trefoil Factor‐3 Is a Hypoxia‐Triggered Pro‐Tumorigenic Factor in Hepatoblastoma
2026 · Luz A. Martínez‐Pérez, M. Ujue Latasa, et al. · Liver International
The disease‐linked R336C mutation in cystathionine β‐synthase disrupts communication with the PLP cofactor, yet maintains the enzyme's overall structural integrity
2025 · Carolina Conter, Reyes Núñez‐Franco, et al. · FEBS Journal · 4
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3
2024 · Maitane Asensio, Oscar Briz, et al. · Biomedicine & Pharmacotherapy · 4
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
2024 · Jasmin Elurbide, Leticia Colyn, et al. · Gut · 30
PDF
Magnesium and Liver Metabolism Through the Lifespan
2023 · Miren Bravo, Jorge Simón, et al. · Advances in Nutrition · 17
Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver
2023 · Luis González-Moreno, Andrea Santamaría-Cano, et al. · Molecular Genetics and Metabolism Reports · 6
Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
2022 · Teresa C. Delgado, Javier de las Heras, et al. · Frontiers in Endocrinology · 36
PDF
Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage
2022 · Irene González-Recio, Jorge Simón, et al. · Nature Communications · 40
A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants
2022 · Leire Egia-Mendikute, Alexandre Bosch, et al. · Frontiers in Immunology · 9
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
2022 · Leticia Colyn, Gloria Alvarez-Sola, et al. · Journal of Experimental & Clinical Cancer Research · 35
PDF
Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors
2022 · Sofia Lachiondo-Ortega 1 , Teresa Cardoso Delgado 1 , Blanca Baños-Jaime 2 , Alejandro Velázquez-Cruz 2 , Irene Díaz-Moreno 2 And María Luz Martínez-Chantar 1,3,* · Zenodo (CERN European Organization for Nuclear Research)
PDF
Year
Topic